About
About Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
Visit company website
5 years, 5 months ago
Voyageur Pharmaceuticals Ltd is currently in a long term uptrend where the price is trading 14.3% above its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Voyageur Pharmaceuticals Ltd's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 34.0% to $-286K since the same quarter in the previous year.
Finally, its free cash flow grew by 31.9% to $-177K since the same quarter in the previous year.
Based on the above factors, Voyageur Pharmaceuticals Ltd gets an overall score of 3/5.